Effect of lignocaine infusion during surgery on fentanyl consumption after surgery in renal transplant patients

EFFECT OF INTRAOPERATIVE 2 PERCENTAGE LIGNOCAINE INFUSION ON POSTOPERATIVE FENTANYL CONSUMPTION IN RENAL TRANSPLANT RECIPIENTS: A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/094537

Enrollment

Registered

2025-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 0.9% normal saline: 0.9% normal saline infusion during surgery to see postoperative fentanyl consumption in renal transplant recipient Control Intervention1: 2% LIGNOCAINE: 2% LIGNOCAIN

Eligibility

Inclusion criteria

Inclusion criteria: 1. Males or Females 2. Age: 18-65 years

Exclusion criteria

Exclusion criteria: 1. Failure to obtain Consent 2. History of lignocaine sensitivity 3. LVEF less than 50% 4. ASA IV (American Society of Anaesthesiology grade IV)

Design outcomes

Primary

Measure	Time frame
Cumulative fentanyl consumptionTimepoint: postoperatively first 24 hours	—

Secondary

Measure	Time frame
1. Intraoperative hemodynamic parameters. 2. Adverse effects like nausea and vomiting within 2 hours, postoperative Timepoint: intraoperative hemodynamic parameters during intraoperative period every 15 minutes nausea and vomiting within 2 hours postoperatively	—

Countries

India

Contacts

Public ContactDr Jagriti Gaur

Sir Ganga Ram Hospital, New Delhi

write2rashmi@yahoo.com9810645865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026